Becoming a qualified treatment center can take six to 18 months, according to Mahmoudjafari. Some institutions begin ...

When catastrophic conditions aren’t treated as their own vertical, plans risk applying standard care or general case management models that lack the depth, coordination, and domain expertise required.

As cell and gene therapies move into more hospitals and cancer centers, health system leaders are learning that clinical success is only part of the equation. These treatments may offer life-changing ...

The role of the pharmacist, managed care pharmacist job satisfaction and artificial intelligence were among the topics that ...

Consistent access to antiretroviral therapy is essential for viral suppression and preventing transmission, and even short-term insurance disruptions can have significant public health consequences ...

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

A number of recent studies suggests that shingles vaccine has benefits beyond just protecting against shingles. A new study ...

In this Q&A, Jessica Vazzaz explained what evidence supports sonic sleep aids, who benefits and what payers should demand ...

The transparency and reporting requirements that are part of the reform bill that President Donald Trump signed into law on ...

Semaglutide, the active ingredient in the anti-obesity drug Wegovy, offers cardiovascular benefits for patients without diabetes who have established heart disease, but price reductions would be ...

Zimbabwe is now one of the first countries in the world to start a lenacapavir program, which was made possible through funding from the United States government and The Global Fund.

NRT duration (two vs eight weeks), and social determinants screening with referral, enabling comparative cost-effectiveness ...